66
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
465898
Mablytics develops a novel oncology diagnostic and therapy based on a unique target.
- Eric Sjoberg: Chief Scientific Oficer and Co-Founder
Sundar Subramaniam: DirectorPast Role: Authess, Founder and Director
About the Company
Mablytics is a preclinical biotechnology startup working on immunotherapies that are given precisely using a unique target. Recent research has found that the novel target is strictly limited in normal tissues, but overexpressed in some malignancies. Immunotherapies aimed at this target have the potential to be extremely successful while causing
minimal side effects. Mablytics is paving the way for a more effective and yet safer immunotherapy by discovering the target's unique expression and creating predictive biomarkers that assess the likelihood of benefit or toxicity from prospective medicines.
